These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12553684)

  • 1. Immune responses against HIV: what we want and what we get.
    Smith D
    J HIV Ther; 2002 May; 7(2):27-9. PubMed ID: 12553684
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Tuberculosis' after commencing antiretroviral therapy in HIV patients from countries where Mycobacterium tuberculosis infection is common.
    French MA
    AIDS; 2006 Feb; 20(3):473-4. PubMed ID: 16439889
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome.
    Kar HK; Sharma P; Bhardwaj M
    Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
    Jones LE; Perelson AS
    Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
    French M; Price P
    J HIV Ther; 2002 May; 7(2):46-51. PubMed ID: 12553688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.
    Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H
    J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.
    Crowe SM; Kornbluth RS
    Med J Aust; 1996 Feb; 164(3):171-3. PubMed ID: 8628138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
    Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
    J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
    Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C
    Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens.
    Atzori C; Clerici M; Trabattoni D; Fantoni G; Valerio A; Tronconi E; Cargnel A
    J Antimicrob Chemother; 2003 Aug; 52(2):276-81. PubMed ID: 12837736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
    Chan DJ
    Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J
    Expert Rev Vaccines; 2007 Apr; 6(2):203-12. PubMed ID: 17408370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.